Sinsin Pharmaceutical Co., Ltd

Informe acción KOSDAQ:A002800

Capitalización de mercado: ₩80.3b

Sinsin Pharmaceutical Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Ki Lee Byoung

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEO0.3%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues

Mar 20
Sinsin Pharmaceutical's (KOSDAQ:002800) Profits May Not Reveal Underlying Issues

What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?

Mar 06
What Kind Of Shareholders Hold The Majority In Sinsin Pharmaceutical Co., Ltd's (KOSDAQ:002800) Shares?

Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?

Feb 08
Is Sinsin Pharmaceutical (KOSDAQ:002800) A Risky Investment?

If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today

Jan 18
If You Had Bought Sinsin Pharmaceutical (KOSDAQ:002800) Stock A Year Ago, You Could Pocket A 24% Gain Today

We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability

Dec 25
We're Not Counting On Sinsin Pharmaceutical (KOSDAQ:002800) To Sustain Its Statutory Profitability

What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?

Nov 29
What Kind Of Investors Own Most Of Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)?

CEO

Ki Lee Byoung

no data

Permanencia

Ki Lee Byoung is President & CEO of Sinsin Pharmaceutical Co., Ltd.